✦ LIBER ✦

A385 Bortezomib-Based Therapy Induces Better Outcomes of Autologous Stem Cell Tranaplantation in Myeloma

✍ Scribed by Kim, SJ; Kim, K; Lee, JH; Kim, MK; Kwak, JY; Ryoo, HM; Suh, C; Yoon, SS; Lee, SS; Mun, YC; Lee, HJ; Min, CK; Kim, JS; Yoon, HJ

Book ID: 118629339
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 91 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70566-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes of autologous stem cell transpl

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy

✍ Anagnostopoulos, A; Aleman, A; Yang, Y; Donato, M; Weber, D; Champlin, R; Smith, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Combination of bortezomib, thalidomide,

Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients

✍ Takashima, Shuichiro; Miyamoto, Toshihiro; Kadowaki, Masanori; Ito, Yoshikiyo; A 📂 Article 📅 2014 🏛 Carden Jennings Publishing 🌐 English ⚖ 185 KB

Bortezomib-Based Versus Nonbortezomib-Ba

Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials

✍ Sonneveld, P.; Goldschmidt, H.; Rosinol, L.; Blade, J.; Lahuerta, J. J.; Cavo, M 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 419 KB

Phase II Trial of Intravenously Administ

Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide Based Initial Therapy

✍ S. Kumar; J. Mikhael; M. Lacy; B. LaPlant; F. Buadi; D. Dingli; M. Gertz; T. Mic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Early response-based intensification of

Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study

✍ Ahn, Seo-Yeon; Jung, Sung-Hoon; Joo, Young Don; Lee, Won Sik; Lee, Sang Min; Cho 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 442 KB

Improved Survival for Multiple Myeloma i

Improved Survival for Multiple Myeloma in Denmark Based on Autologous Stem Cell Transplantation and Novel Drug Therapy in Collaborative Trials: Analysis of Accrual, Prognostic Variables, Selection Bias, and Clinical Behavior on Survival in More Than 1200 Patients in Trials of the Nordic Myeloma Study Group

✍ Hans E. Johnsen; Tobias W. Klausen; Martin Boegsted; Stig Lenhoff; Peter Gimsing 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 143 KB